论文部分内容阅读
目的:评价预防性应用选择性环氧化酶-2(COX-2)抑制剂塞莱昔布对化学诱导大鼠乳腺肿瘤及正常乳腺组织病理分级的影响。方法:雌性SD大鼠予二甲基苯并蒽(DMBA)1次性灌胃诱发乳腺肿瘤过程中,给予不同剂量塞莱昔布,观察肿瘤发生率、数量和体积,并与正常对照组进行病理学分析。结果:与对照组相比,塞莱昔布100和150 mg/kg两剂量组大鼠乳腺肿瘤发生率和肿瘤数量均显著低于模型对照组,但各组间肿瘤平均体积差异无统计学意义,P>0.05。塞莱昔布显著降低大鼠乳腺肿瘤的组织病理分级(100 mg/kg,P=0.021;150 mg/kg,P=0.036),显著降低DMBA导致的乳腺小叶和腺泡的病变程度(100 mg/kg,P=0.004)。结论:预防性应用塞莱昔布具有降低乳腺肿瘤的病理分级,保护正常乳腺组织的作用,其临床应用价值值得进一步探索。
Objective: To evaluate the effect of prophylactic use of selective cyclooxygenase-2 (COX-2) inhibitor celecoxib on chemically-induced breast tumor and normal breast tissue pathological grading. Methods: Female Sprague-Dawley rats were given intragastric administration of DMBA intragastrically for one-time intragastric administration of celecoxib. The incidence, volume and volume of the tumor were observed and compared with the normal control group Pathological analysis. Results: Compared with the control group, the incidence of breast cancer and the number of tumors in both celecoxib 100 and 150 mg / kg groups were significantly lower than those in the model control group, but there was no significant difference in average tumor volume among the groups , P> 0.05. Celecoxib significantly reduced histopathological grade (100 mg / kg, P = 0.021; 150 mg / kg, P = 0.036) and significantly reduced the degree of lesion of the mammary gland lobes and acini caused by DMBA (100 mg /kg,P=0.004). Conclusion: Prophylactic application of celecoxib has the function of reducing the pathological grade of breast tumors and protecting the normal breast tissue, and its clinical value is worth further exploration.